FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 26436-5457 | 26436-5457-1 | TESTOSTERONE 25mg | TESTOSTERONE 25mg | 25 mg/1 g | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5356 | 26436-5356-1 | TESTOSTERONE 3mg | TESTOSTERONE 3mg | 3 mg/1 g | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5600 | 26436-5600-5 | Testosterone Cypionate 20mg/mL | Testosterone Cypionate 20mg/mL | 20 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5630 | 26436-5630-1 | TETRACAINE 6 | TETRACAINE 6 | 60 mg/1 g | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-6029 | 26436-6029-3 | Thiamine B1 100mg/mL | Thiamine Hydrochloride (B1) | 100 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5622 | 26436-5622-5 | TIRZEPATIDE 10MG/ML | TIRZEPATIDE 10MG/ML | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5636 | 26436-5636-3 | TIRZEPATIDE 20MG/ML | TIRZEPATIDE 20MG/ML | 20 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5037 | 26436-5037-1 | Trimix 10/30/1 | Trimix 10/30/1 | 10 ug/1 mL; 30 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5137 | 26436-5137-5 | Trimix 20/30/2 | Trimix 20/30/2 | 30 mg/1 mL; 20 ug/1 mL; 2 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5141 | 26436-5141-5 | Trimix 40/30/2 | Trimix 40/30/2 | 40 ug/1 mL; 30 mg/1 mL; 2 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5112 | 26436-5112-5 | Trimix 40/30/3 | Trimix 40/30/3 | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5601 | 26436-5601-5 | Trimix 40/30/4 | Trimix 40/30/4 | 4 mg/1 mL; 40 mg/1 mL; 30 ug/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5097 | 26436-5097-5 | Trimix 60/30/3 | Trimix 60/30/3 | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5609 | 26436-5609-5 | Trimix 8.3/22.5/0.83 | ALPROSTADIL, PAPAVERINE, PHENTOLAMINE 8.3/22.5/0.83 | 8.3 ug/1 mL; 22.5 mg/1 mL; .83 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-6010 | 26436-6010-3 | Zinc Sulfate heptahydrate10mg/mL | Zinc Sulfate10mg/mL | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-6030 | 71139-6030-1 | Fentanyl Citrate CADD | Fentanyl Citrate CADD | 2500 ug/50 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-5340 | 71139-5340-4 | Fentanyl Citrate with Ropivacaine Hydrochlorid | Fentanyl Citrate with Ropivacaine Hydrochloride | 200 mg/200 mL; 400 ug/200 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-5340 | 71139-5340-2 | Fentanyl Citrate with Ropivacaine Hydrochlorid | Fentanyl Citrate with Ropivacaine Hydrochloride | 200 mg/200 mL; 400 ug/200 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-0018 | 71139-0018-1 | Hydromorphone HYDROCHLORIDE CADD | Hydromorphone HYDROCHLORIDE CADD | 20 mg/100 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-0012 | 71139-0012-1 | Oxytocin | Oxytocin | 30 U/500 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-7084 | 71139-7084-2 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-5355 | 71139-5355-2 | Sugammadex | Sugammadex | 200 mg/2 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-5355 | 71139-5355-1 | Sugammadex | Sugammadex | 200 mg/2 mL | 2025-2 | valid | 2026-09-18 | |
| IntegraDose Compounding Services, LLC | 71139-0190 | 71139-0190-1 | Vasopressin | Vasopressin | 2 U/2 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 025104311 | 68985-040 | 68985-040-94 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-004 | 68985-004-91 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-629 | 68985-629-91 | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-324 | 68985-324-93 | Vancomycin Hydrochloride | 6 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-304 | 68985-304-92 | Vancomycin Hydrochloride | 5 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-925 | 68985-925-95 | Dexmedetomidine Hydrochloride | 4 mg/1000 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-615 | 68985-615-91 | Diltiazem Hydrochloride | 1 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-153 | 68985-153-85 | Amiodarone Hydrochloride | 1.8 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-540 | 68985-540-95 | Heparin Sodium | 10 U/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-540 | 68985-540-91 | Heparin Sodium | 10 U/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-486 | 68985-486-93 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 20 mg/1 mL; 20 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 8 mg/250 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-012 | 68985-012-93 | Oxytocin | 30 U/500 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 025104311 | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| LEESAR INC | 68985-153 | 68985-153-85 | Amiodarone HCl 900mg | Amiodarone HCl 900mg | 1.8 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-112 | 68985-112-91 | Azithromycin 500mg | Azithromycin 500mg | 2 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-925 | 68985-925-95 | Dexmedetomidine HCl 4mcg/mL | Dexmedetomidine HCl IN 0.9% NaCl | 4 mg/1000 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-615 | 68985-615-91 | Diltiazem HCl 125mg | Diltiazem HCl 125mg | 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-540 | 68985-540-95 | Heparin Sodium | Heparin Sodium | 10 U/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-540 | 68985-540-91 | Heparin Sodium | Heparin Sodium | 10 U/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-234 | 68985-234-91 | Hydromorphone HCl 50mg | Hydromorphone HCl 50mg | .2 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-486 | 68985-486-93 | Lidocaine HCl 2% 20mg/mL | Lidocaine HCl 2% 20mg/mL | 20 mg/1 mL; 20 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate 8mg | Norepinephrine Bitartrate 8mg | 8 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| LEESAR INC | 68985-012 | 68985-012-93 | Oxytocin 30U | Oxytocin 30U | 30 U/500 mL | 2025-2 | valid | 2026-09-18 |